Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Prives

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Journal of Molecular Cell Biology|July 9, 2019
Gain-of-function mutant p53: history and speculationJill Bargonetti, Carol Prives
Cold Spring Harbor Perspectives in Biology|August 4, 2010
Transcriptional regulation by p53Rachel Beckerman, Carol Prives
Cell|February 26, 2004
p53 in the cytoplasm: a question of overkill?Nicole Baptiste, Carol Prives
Seminars in Cell & Developmental Biology|April 21, 2005
The S phase checkpoint: when the crowd meets at the forkVanesa Gottifredi, Carol Prives
Genes & Development|May 17, 2008
Does control of mutant p53 by Mdm2 complicate cancer therapy?Carol Prives, Eileen White
Cell Cycle (Georgetown, Tex.)|December 11, 2008
The p21 and PCNA partnership: a new twist for an old plotCarol Prives, Vanesa Gottifredi
Cell|March 29, 2024
p53: A tale of complexity and contextMoshe Oren, Carol Prives
Molecular Cell|November 18, 2009
p53 and Metabolism: The GAMT ConnectionYan Zhu, Carol Prives
The Journal of Biological Chemistry|October 19, 2002
Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylationJinwoo Ahn, Carol Prives
Molecular and Cellular Biology|September 7, 2002
Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 proteinKristine McKinney, Carol Prives
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Journal of Molecular Cell Biology|July 9, 2019
Gain-of-function mutant p53: history and speculationJill Bargonetti, Carol Prives
Cold Spring Harbor Perspectives in Biology|August 4, 2010
Transcriptional regulation by p53Rachel Beckerman, Carol Prives
Cell|February 26, 2004
p53 in the cytoplasm: a question of overkill?Nicole Baptiste, Carol Prives
Seminars in Cell & Developmental Biology|April 21, 2005
The S phase checkpoint: when the crowd meets at the forkVanesa Gottifredi, Carol Prives
Genes & Development|May 17, 2008
Does control of mutant p53 by Mdm2 complicate cancer therapy?Carol Prives, Eileen White
Cell Cycle (Georgetown, Tex.)|December 11, 2008
The p21 and PCNA partnership: a new twist for an old plotCarol Prives, Vanesa Gottifredi
Cell|March 29, 2024
p53: A tale of complexity and contextMoshe Oren, Carol Prives
Molecular Cell|November 18, 2009
p53 and Metabolism: The GAMT ConnectionYan Zhu, Carol Prives
The Journal of Biological Chemistry|October 19, 2002
Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylationJinwoo Ahn, Carol Prives
Molecular and Cellular Biology|September 7, 2002
Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 proteinKristine McKinney, Carol Prives
Pageof 13